Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Qingdu Anshen capsule in chronic renal failure
CTR20131431Phase 2Completed
- Start
- Nov 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of Qingdu Anshen in chronic kidney disease (CKD) (3 arms). Primary endpoints: Glomerular filtration rate (GFR) and Traditional Chinese medicine (TCM) composite symptom score. Started Nov 2013; status: completed.
02
Drugs
Qingdu Anshen
03
Conditions
chronic kidney disease (CKD)
Beyond the preview
Go deeper on CTR20131431.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20131431.